Cargando…

MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro

Elite controllers maintain HIV-1 viral loads below the limit of detection. The mechanisms responsible for this phenomenon are poorly understood. As microRNAs (miRNAs) are regulators of gene expression and some of them modulate HIV infection, we have studied the miRNA profile in plasma from HIV elite...

Descripción completa

Detalles Bibliográficos
Autores principales: Reynoso, Rita, Laufer, Natalia, Hackl, Matthias, Skalicky, Susanna, Monteforte, Rossella, Turk, Gabriela, Carobene, Mauricio, Quarleri, Jorge, Cahn, Pedro, Werner, Roland, Stoiber, Heribert, Grillari-Voglauer, Regina, Grillari, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118195/
https://www.ncbi.nlm.nih.gov/pubmed/25081906
http://dx.doi.org/10.1038/srep05915
_version_ 1782328803408740352
author Reynoso, Rita
Laufer, Natalia
Hackl, Matthias
Skalicky, Susanna
Monteforte, Rossella
Turk, Gabriela
Carobene, Mauricio
Quarleri, Jorge
Cahn, Pedro
Werner, Roland
Stoiber, Heribert
Grillari-Voglauer, Regina
Grillari, Johannes
author_facet Reynoso, Rita
Laufer, Natalia
Hackl, Matthias
Skalicky, Susanna
Monteforte, Rossella
Turk, Gabriela
Carobene, Mauricio
Quarleri, Jorge
Cahn, Pedro
Werner, Roland
Stoiber, Heribert
Grillari-Voglauer, Regina
Grillari, Johannes
author_sort Reynoso, Rita
collection PubMed
description Elite controllers maintain HIV-1 viral loads below the limit of detection. The mechanisms responsible for this phenomenon are poorly understood. As microRNAs (miRNAs) are regulators of gene expression and some of them modulate HIV infection, we have studied the miRNA profile in plasma from HIV elite controllers and chronically infected individuals and compared against healthy donors. Several miRNAs correlate with CD4+ T cell count or with the known time of infection. No significant differences were observed between elite controllers and healthy donors; however, 16 miRNAs were different in the plasma of chronic infected versus healthy donors. In addition, levels of hsa-miR-29b-3p, hsa-miR-33a-5p and hsa-miR-146a-5p were higher in plasma from elite controllers than chronic infected and hsa-miR-29b-3p and hsa-miR-33a-5p overexpression significantly reduced the viral production in MT2 and primary T CD4+ cells. Therefore, levels of circulating miRNAs might be of diagnostic and/or prognostic value for HIV infection, and hsa-miR-29b-3p and miR-33a-5p may contribute to the design of new anti-HIV drugs.
format Online
Article
Text
id pubmed-4118195
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-41181952014-08-15 MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro Reynoso, Rita Laufer, Natalia Hackl, Matthias Skalicky, Susanna Monteforte, Rossella Turk, Gabriela Carobene, Mauricio Quarleri, Jorge Cahn, Pedro Werner, Roland Stoiber, Heribert Grillari-Voglauer, Regina Grillari, Johannes Sci Rep Article Elite controllers maintain HIV-1 viral loads below the limit of detection. The mechanisms responsible for this phenomenon are poorly understood. As microRNAs (miRNAs) are regulators of gene expression and some of them modulate HIV infection, we have studied the miRNA profile in plasma from HIV elite controllers and chronically infected individuals and compared against healthy donors. Several miRNAs correlate with CD4+ T cell count or with the known time of infection. No significant differences were observed between elite controllers and healthy donors; however, 16 miRNAs were different in the plasma of chronic infected versus healthy donors. In addition, levels of hsa-miR-29b-3p, hsa-miR-33a-5p and hsa-miR-146a-5p were higher in plasma from elite controllers than chronic infected and hsa-miR-29b-3p and hsa-miR-33a-5p overexpression significantly reduced the viral production in MT2 and primary T CD4+ cells. Therefore, levels of circulating miRNAs might be of diagnostic and/or prognostic value for HIV infection, and hsa-miR-29b-3p and miR-33a-5p may contribute to the design of new anti-HIV drugs. Nature Publishing Group 2014-08-01 /pmc/articles/PMC4118195/ /pubmed/25081906 http://dx.doi.org/10.1038/srep05915 Text en Copyright © 2014, Macmillan Publishers Limited. All rights reserved http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder in order to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Reynoso, Rita
Laufer, Natalia
Hackl, Matthias
Skalicky, Susanna
Monteforte, Rossella
Turk, Gabriela
Carobene, Mauricio
Quarleri, Jorge
Cahn, Pedro
Werner, Roland
Stoiber, Heribert
Grillari-Voglauer, Regina
Grillari, Johannes
MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro
title MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro
title_full MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro
title_fullStr MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro
title_full_unstemmed MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro
title_short MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro
title_sort micrornas differentially present in the plasma of hiv elite controllers reduce hiv infection in vitro
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118195/
https://www.ncbi.nlm.nih.gov/pubmed/25081906
http://dx.doi.org/10.1038/srep05915
work_keys_str_mv AT reynosorita micrornasdifferentiallypresentintheplasmaofhivelitecontrollersreducehivinfectioninvitro
AT laufernatalia micrornasdifferentiallypresentintheplasmaofhivelitecontrollersreducehivinfectioninvitro
AT hacklmatthias micrornasdifferentiallypresentintheplasmaofhivelitecontrollersreducehivinfectioninvitro
AT skalickysusanna micrornasdifferentiallypresentintheplasmaofhivelitecontrollersreducehivinfectioninvitro
AT monteforterossella micrornasdifferentiallypresentintheplasmaofhivelitecontrollersreducehivinfectioninvitro
AT turkgabriela micrornasdifferentiallypresentintheplasmaofhivelitecontrollersreducehivinfectioninvitro
AT carobenemauricio micrornasdifferentiallypresentintheplasmaofhivelitecontrollersreducehivinfectioninvitro
AT quarlerijorge micrornasdifferentiallypresentintheplasmaofhivelitecontrollersreducehivinfectioninvitro
AT cahnpedro micrornasdifferentiallypresentintheplasmaofhivelitecontrollersreducehivinfectioninvitro
AT wernerroland micrornasdifferentiallypresentintheplasmaofhivelitecontrollersreducehivinfectioninvitro
AT stoiberheribert micrornasdifferentiallypresentintheplasmaofhivelitecontrollersreducehivinfectioninvitro
AT grillarivoglauerregina micrornasdifferentiallypresentintheplasmaofhivelitecontrollersreducehivinfectioninvitro
AT grillarijohannes micrornasdifferentiallypresentintheplasmaofhivelitecontrollersreducehivinfectioninvitro